{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:12:34Z","timestamp":1788412354382,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.urolonc.2023.04.017","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T15:55:54Z","timestamp":1684425354000},"page":"356.e11-356.e18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Survival outcomes in patients with muscle invasive bladder cancer undergoing radical vs. partial cystectomy"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5916-0477","authenticated-orcid":false,"given":"Rainjade","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George W.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyad","family":"Movassaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Ingram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Lenis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"McKiernan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izak","family":"Faiena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.urolonc.2023.04.017_bib0001","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1200\/JOP.2017.024919","article-title":"Treatment of nonmetastic muscle-invasive bladder cancer: American Urological Association\/American Society of Clinical Oncology\/American Society for Radiation Oncology\/Society of Urologic Oncology Clinical practice Guideline summary","volume":"13","author":"Chang","year":"2017","journal-title":"J Oncol Pract"},{"issue":"1","key":"10.1016\/j.urolonc.2023.04.017_bib0002","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European association of urology guidelines on muscle-invasive and metastic bladder cancer: summary of the 2020 Guidelines","volume":"79","author":"Witjes","year":"2021","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2023.04.017_bib0003","doi-asserted-by":"crossref","first-page":"329","DOI":"10.6004\/jnccn.2020.0011","article-title":"Bladder Cancer, version 3.2020, NCCN Clinical Practice Guidelines in Oncology","volume":"18","author":"Flaig","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"10.1016\/j.urolonc.2023.04.017_bib0004","first-page":"7520","article-title":"Performance of partial cystectomy in the United States from 2001 to 2010: trends and comparative outcomes","volume":"21","author":"Faiena","year":"2014","journal-title":"Can J Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2023.04.017_bib0005","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0022-5347(17)60608-6","article-title":"Segmental resection for carcinoma of the bladder: review of 102 patients","volume":"109","author":"Resnick","year":"1973","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2023.04.017_bib0006","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0022-5347(17)58915-6","article-title":"Partial cystectomy in the treatment of primary and secondary carcinoma of the bladder","volume":"116","author":"Novick","year":"1976","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2023.04.017_bib0007","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1200\/JCO.1998.16.4.1298","article-title":"Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome","volume":"16","author":"Herr","year":"1998","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2023.04.017_bib0008","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/jso.2930600106","article-title":"Partial cystectomy for invasive bladder cancer","volume":"60","author":"Dandekar","year":"1995","journal-title":"J Surg Oncol"},{"issue":"4","key":"10.1016\/j.urolonc.2023.04.017_bib0009","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.juro.2012.06.029","article-title":"Does partial cystectomy compromise oncologic outcomes for patients with bladder cancer compared to radical cystectomy? A matched case-control analysis","volume":"188","author":"Knoedler","year":"2012","journal-title":"J Urol"},{"issue":"14","key":"10.1016\/j.urolonc.2023.04.017_bib0010","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1200\/JCO.2004.11.024","article-title":"Surgical factors influence bladder cancer outcomes: a cooperative group report","volume":"22","author":"Herr","year":"2004","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.urolonc.2023.04.017_bib0011","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1001\/jamaoncol.2016.6905","article-title":"Using the National Cancer Database for Outcomes Research: A Review","volume":"3","author":"Boffa","year":"2017","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2023.04.017_bib0012","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1464-410X.2012.11693.x","article-title":"Extent of lymphadenectomy does not improve the survival of patients with renal cell carcinoma and nodal metastases: biases associated with the handling of missing data","volume":"113","author":"Sun","year":"2014","journal-title":"BJU Int"},{"issue":"23","key":"10.1016\/j.urolonc.2023.04.017_bib0013","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1200\/JCO.2013.49.5283","article-title":"Challenges of guarantee-time bias","volume":"31","author":"Giobbie-Hurder","year":"2013","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.urolonc.2023.04.017_bib0014","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/01.ju.0000135530.59860.7d","article-title":"Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection","volume":"172","author":"Holzbeierlein","year":"2004","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2023.04.017_bib0015","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.urology.2008.04.052","article-title":"Long-term results of selective partial cystectomy for invasive urothelial bladder carcinoma","volume":"72","author":"Smaldone","year":"2008","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.urolonc.2023.04.017_bib0016","doi-asserted-by":"crossref","first-page":"8360","DOI":"10.1038\/s41598-018-26089-x","article-title":"Oncological outcomes, quality of life outcomes and complications of partial cystectomy for selected cases of muscle-invasive bladder cancer","volume":"8","author":"Ebbing","year":"2018","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.urolonc.2023.04.017_bib0017","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/S0022-5347(06)00322-3","article-title":"Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience","volume":"175","author":"Kassouf","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2023.04.017_bib0018","article-title":"Partial Cystectomy after Neoadjuvant Chemotherapy: Memorial Sloan Kettering Cancer Center Contemporary Experience","volume":"2014","author":"Bazzi","year":"2014","journal-title":"Int Sch Res Notices."},{"issue":"6 Pt B","key":"10.1016\/j.urolonc.2023.04.017_bib0019","first-page":"E203","article-title":"Pathology-based risk stratification of muscle-invasive bladder cancer patients undergoing cystectomy for persistent disease after induction chemoradiotherapy in bladder-sparing approaches","volume":"110","author":"Koga","year":"2012","journal-title":"BJU Int"},{"issue":"8","key":"10.1016\/j.urolonc.2023.04.017_bib0020","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.urolonc.2021.01.016","article-title":"The role of neoadjuvant chemotherapy, lymph node dissection, and treatment delay in patients with muscle-invasive bladder cancer undergoing partial cystectomy","volume":"39","author":"Lenis","year":"2021","journal-title":"Urol Oncol"},{"issue":"4","key":"10.1016\/j.urolonc.2023.04.017_bib0021","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.urology.2009.03.052","article-title":"Partial cystectomy does not undermine cancer control in appropriately selected patients with urothelial carcinoma of the bladder: a population-based matched analysist","volume":"74","author":"Capitanio","year":"2009","journal-title":"Urology"},{"issue":"12","key":"10.1016\/j.urolonc.2023.04.017_bib0022","doi-asserted-by":"crossref","first-page":"412","DOI":"10.5489\/cuaj.4403","article-title":"Partial cystectomy for urothelial carcinoma of the bladder: Practice patterns and outcomes in the general population","volume":"11","author":"Leveridge","year":"2017","journal-title":"Can Urol Assoc J"},{"issue":"1","key":"10.1016\/j.urolonc.2023.04.017_bib0023","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.eururo.2014.02.038","article-title":"Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review","volume":"66","author":"Ploussard","year":"2014","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2023.04.017_bib0024","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.critrevonc.2015.04.006","article-title":"Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: a systematic review of clinical trials","volume":"95","author":"Arcangeli","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"10.1016\/j.urolonc.2023.04.017_bib0025","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.eururo.2016.12.020","article-title":"Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience","volume":"71","author":"Giacalone","year":"2017","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2023.04.017_bib0026","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1464-410X.2011.10425.x","article-title":"Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients","volume":"109","author":"Koga","year":"2012","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.urolonc.2023.04.017_bib0027","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/bju.14736","article-title":"Selective tetramodal bladder-preservation therapy, incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymph node dissection for muscle-invasive bladder cancer: oncological and functional outcomes of 107 patients","volume":"124","author":"Kijima","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2023.04.017_bib0028","doi-asserted-by":"crossref","first-page":"b2393","DOI":"10.1136\/bmj.b2393","article-title":"Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls","volume":"338","author":"Sterne","year":"2009","journal-title":"BMJ"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143923001370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143923001370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:28:14Z","timestamp":1761042494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143923001370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1078143923001370"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2023.04.017","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival outcomes in patients with muscle invasive bladder cancer undergoing radical vs. partial cystectomy","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2023.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}